Evidence map›Paper›PMID 36901929›Full record

ArticleInternational journal of molecular sciences2023

MSEDDI: Multi-Scale Embedding for Predicting Drug-Drug Interaction Events.

Liyi Yu, Zhaochun Xu, Meiling Cheng, Weizhong Lin, Wangren Qiu, Xuan Xiao

Full text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liyi YuDepartment of Computer, School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, China.ORCID 0000-0002-7428-4849
Zhaochun XuDepartment of Computer, School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, China.ORCID 0000-0003-1799-5529
Meiling ChengDepartment of Computer, School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, China.
Weizhong LinDepartment of Computer, School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, China.
Wangren QiuDepartment of Computer, School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, China.
Xuan XiaoDepartment of Computer, School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, China.ORCID 0000-0003-1016-7544

Funding

Department of Education of Jiangxi Province GJJ211349National Natural Science Foundation of China 32270789, 62062043, 32260154, 62162032Science and Technology Plan Project of Jingdezhen City, China 20212GYZD009-01
6 · The paper itself

Abstract

A norm in modern medicine is to prescribe polypharmacy to treat disease. The core concern with the co-administration of drugs is that it may produce adverse drug-drug interaction (DDI), which can cause unexpected bodily injury. Therefore, it is essential to identify potential DDI. Most existing methods in silico only judge whether two drugs interact, ignoring the importance of interaction events to study the mechanism implied in combination drugs. In this work, we propose a deep learning framework named MSEDDI that comprehensively considers multi-scale embedding representations of the drug for predicting drug-drug interaction events. In MSEDDI, we design three-channel networks to process biomedical network-based knowledge graph embedding, SMILES sequence-based notation embedding, and molecular graph-based chemical structure embedding, respectively. Finally, we fuse three heterogeneous features from channel outputs through a self-attention mechanism and feed them to the linear layer predictor. In the experimental section, we evaluate the performance of all methods on two different prediction tasks on two datasets. The results show that MSEDDI outperforms other state-of-the-art baselines. Moreover, we also reveal the stable performance of our model in a broader sample set via case studies.

Indexed as

Knowledge BasesPolypharmacyDrug InteractionsHumansdrug—drug interactiongraph neural networkknowledge graphself-attention mechanism

Identifiers

PMID36901929
PMCPMC10002564

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
table measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.